A Northwestern Medicine study has revealed a previously unknown connection between two fundamental cellular processes, ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

Despite these advances, the synthesis of DNA nanostructures has remained a largely manual and time-consuming process. Traditional approaches often require the precise mixing of hundreds of unique DNA ...

Demand for synthetic DNA is growing across multiple industries including cell and gene therapy development and biomanufacturing. Coupled with that growth is a need for genetic constructs that can, in ...

There’s an old saying about a dollar waiting on a dime. In other words, a monumental endeavor may become stuck at some point if a key preliminary element remains unavailable. The saying could be ...

Researchers have begun working on a new, controversial project to produce human DNA from scratch. It is believed to be the first of its kind effort which, if successful, could lead to new treatments ...

AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...

Researchers at The Institute of Cancer Research, London identified the CIP2A–TOPBP1 complex as a master regulator of DNA repair during mitosis, coordinating backup pathways that protect chromosomes ...

Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B round of financing that will be used to expand the company’s DNA synthesis production capacity in the U.S. The San ...